We break down the stocks Chuck Akre (Akre) bought, sold, and held in Q1 2024, including their holdings at the end of the quarter. All data sourced from Akre's 13F filed on May 13, 2024.
Who are Chuck Akre and Akre?
Akre Capital Management is an investment firm founded in 1989 by Charles "Chuck" Akre, known for his "three-legged stool" approach to identifying exceptional investments. The firm focuses on a concentrated portfolio of extraordinary businesses characterized by superior returns on capital, talented and ethical management teams, and the ability to reinvest free cash flow at high rates of return. This disciplined strategy has enabled Akre to deliver market-beating returns over multiple decades through long-term ownership of compounding machines rather than frequent trading.
Akrecapital.com
Wikipedia on Chuck Akre
Portfolio Changes in Q1 2024
New positions
Akre established three new positions in Q1 2024, with the largest being Uber (UBER) at 1.8 million shares worth $137 million, followed by CCC Intelligent Solutions (CCCS) with 7 million shares valued at $84 million, and a smaller stake in Sophia Genetics (SOPH) worth $1.4 million.
Bought
Akre made only one modest addition to existing holdings, slightly increasing their position in CoStar (CSGP) by approximately 6,000 shares.
Sold
Akre significantly reduced or trimmed numerous positions during the quarter, with the most dramatic being an almost complete exit from Brookfield Asset Management (BAM) (selling 98% of the position) and Dollar Tree (DLTR) (selling 90% of the position). Other notable reductions included trimming positions in KKR by 1.8 million shares, American Tower (AMT) by 607,000 shares, Mastercard (MA) by 452,000 shares, Moody's (MCO) by 324,000 shares, and smaller trims across holdings including DigitalBridge (DBRG), Visa (V), Brookfield (BN), O'Reilly Automotive (ORLY), Roper Technologies (ROP), CarMax (KMX), and Berkshire Hathaway (BRK-B).
New Investments in Q1 2024
| Ticker | Company | Weight | Change | Value |
|---|---|---|---|---|
| UBER | Uber | 61.6% | NEW | $136.66M |
| CCCS | CCC Intelligent Solutions | 37.7% | NEW | $83.72M |
| SOPH | Sophia Genetics | 0.6% | NEW | $1.42M |
Uber UBER
Chuck Akre bought $136.66M of Uber in Q1 2024. Uber demonstrated strong profitability in Q1 2025 with 14% YoY revenue growth to $11.5B and 35% YoY adjusted EBITDA growth to $1.9B, though shares fell 6% due to a revenue miss. The company achieved $2.3B in free cash flow while scaling autonomous vehicle initiatives with five new AV partnerships. While trip volume grew 18% YoY, Q2 guidance suggests moderating growth expectations despite continued operational efficiency gains.
- 35% YoY EBITDA growth to $1.9B with 18% YoY trip growth to 3.0B in Q1.
- $2.3B free cash flow generated in quarter, up from $549M YoY.
- Shares declined 6% post-earnings despite profits, reflecting $11.5B revenue missing $11.6B estimates.
CCC Intelligent Solutions CCCS
Chuck Akre bought $83.72M of CCC Intelligent Solutions in Q1 2024. CCC Intelligent Solutions (CCCS) demonstrated strong revenue growth in Q1 2025 with 11% year-over-year increase to $251.6M, though profitability metrics showed mixed results. While adjusted EBITDA margin remained robust at 39%, GAAP net loss widened to $17.4M from $0.6M in the prior year quarter. The company's SaaS platform continues to gain traction in the insurance sector, though investors should monitor its transition to sustained profitability.
- Q1 2025 revenue growth of 11% YoY ($251.6M vs. $227.2M).
- Adjusted EBITDA margin maintained at 39% despite GAAP net loss expansion.
- GAAP net loss increased to $17.4M from $0.6M in Q1 2024.
Sophia Genetics SOPH
Chuck Akre bought $1.42M of Sophia Genetics in Q1 2024. SOPHiA GENETICS demonstrated accelerating growth in Q1 2025 with 13% YoY revenue growth ($17.8M) and a record 75.7% adjusted gross margin, while improving adjusted EBITDA loss by 24%. The company is gaining momentum through expanded partnerships with major institutions and adoption of its MSK-ACCESS platform, though faces profitability challenges with a 27% increase in IFRS net loss ($17.4M). Management maintains 2025 guidance projecting 10-17% annual revenue growth ($72-76M) and expects to approach EBITDA breakeven by late 2026.
- 15% constant currency revenue growth in Q1 2025 driven by 2024 contract ramp-up.
- 490 core genomics customers (+11% analysis volume) and 2M+ cumulative genomic profiles analyzed.
- 30%+ U.S. revenue growth with new partnerships including Mount Sinai and Mayo Clinic.
Holdings at the end of Q1 2024
| Ticker | Company | Weight | Change | Value |
|---|---|---|---|---|
| MA | Mastercard | 18.4% | Trimmed (-9%) | $2.22B |
| MCO | Moody's | 14.5% | Trimmed (-7%) | $1.75B |
| KKR | KKR | 12.4% | Trimmed (-11%) | $1.5B |
| AMT | American Tower | 10.1% | Trimmed (-9%) | $1.22B |
| ORLY | O'Reilly Automotive | 9.2% | Trimmed (-3%) | $1.12B |
| V | Visa | 7.6% | Trimmed (-7%) | $913.08M |
| ROP | Roper Technologies | 7.2% | Trimmed (-2%) | $866.33M |
| BN | Brookfield | 6.2% | Trimmed (-1%) | $751.92M |
| CSGP | CoStar | 5.8% | Added (+0%) | $701.47M |
| DHR | Danaher | 3.7% | $443.35M | |
| KMX | CarMax | 1.9% | Trimmed (-1%) | $235.36M |
| UBER | Uber | 1.1% | NEW | $136.66M |
| CCCS | CCC Intelligent Solutions | 0.7% | NEW | $83.72M |
| DBRG | DigitalBridge | 0.7% | Trimmed (-7%) | $79.18M |
| SBAC | SBA Communications | 0.3% | $39.14M | |
| GSHD | Goosehead | 0.1% | $16.23M | |
| BRK-B | Berkshire Hathaway | 0.1% | Trimmed (-0%) | $6.93M |
| VRSK | Verisk | 0.0% | $4.08M | |
| BAM | Brookfield Asset Management | 0.0% | Trimmed (-98%) | $2.65M |
| SOPH | Sophia Genetics | 0.0% | NEW | $1.42M |
| DLTR | Dollar Tree | 0.0% | Trimmed (-90%) | $296.79K |
Disclaimer: All posts on Scout are for informational purposes only. They are NOT a recommendation to buy or sell the securities discussed. Please do your own research and due diligence before investing your money.
